Acomplia Information Resource
Welcome to the Acomplia information web site. If you, like millions of people around the world, struggle to keep your weight down, you cannot fail to have heard about Acomplia, purported to be the new wonder slimming drug. In clinical trials, over one year a third of patients lost 10% of their initial bodyweight, whilst nearly two thirds of patients on the trial lost over 5% of their initial bodyweight.
So that you can make an informed decision about this drug, this site has been created to provide a dedicated information resource about Acomplia, together with a forum where you can discuss your own experiences with the drug and slimming in general and learn from the experiences of others.
Sales of Acomplia have temporarily been suspended. See Latest News for further details.
Acomplia in the UK and EU
Acomplia has been approved for use within the EU and was available to patients in the UK from June 28th, 2006. The drug was approved by NICE (the National Institute for Health and Clinical Excellence) on June 24th, 2008.
Acomplia is likely to only be available on the NHS to patients who are clinically obese (they have a BMI in excess of 30) or overweight (they have a BMI in excess of 27) and exhibiting other clinical indications such as type II diabetes or an unsatisfactory blood lipid profile.
In all cases where Acomplia is prescribed on the NHS, the patients concerned must have already demonstrated that they have tried diet and exercise to lose weight, and they must try to maintain these efforts whilst taking the pill.
Acomplia in the US
Sanofi-Aventis applied for regulatory approval with the FDA in the US back in April 2005. However, in February 2006, the FDA stated that final approval would not be granted until some additional issues were satisfactorily resolved. It was not stated what these additional issues were. Given these delays, this drug is unlikely to get approval in the US anytime soon.